期刊文献+

脯氨酸肽酶与乙型肝炎患者肝纤维化的关系分析 被引量:3

The relationship of PLD and liver fibrosis in chronic hepatitis B patients
下载PDF
导出
摘要 目的了解血清脯氨酸肽酶(PLD)与乙型病毒性肝炎纤维化程度的关系。方法测定217例乙型肝炎患者血清中PLD水平,利用ROC曲线分析丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、AST/ALT和PLD的曲线下面积,判断PLD的最优截断点并计算不同PLD水平的灵敏度、特异度、阳性预测值(PPV)、阴性预测值(NPV)、Youden指数。结果慢性乙型肝炎患者PLD值随着肝组织纤维化严重程度升高,各组之间比较差异有统计学意义(P<0.01)。ALT、AST、AST/ALT和PLD的ROC曲线下面积分别为0.600,0.642,0.662和0.794。PLD的最优截断点约为1 230 U/L,灵敏度和特异度分别为76.0%和74.4%。结论血清PLD测定对于慢性乙型肝炎患者肝组织纤维化程度判定有一定的临床价值。 Objective To study the relationship of prolidase (PLD) and liver fibrosis in chronic hepatitis B patients. Methods PLD activity in serum collected from 217 patients with hepatitis B were determined. To employ receiver operating characteristic curve (ROC) to evaluate diagnostic value of PLD activity. Results The AU- ROC of ALT,AST,AST/ALT and PLD was 0. 600,0. 642,0. 662 and 0. 794, respectively. The optimal cut-off value of PLD was 1230U/L. Sensitivity and specificity were 76.0% and 74.4% respectively. Conclusion PLD is a potent marker for assessing liver fibrosis stage in chronic hepatitis B patients.
作者 程大也
出处 《山西医药杂志(上半月)》 CAS 2010年第2期102-103,共2页 Shanxi Medical Journal
基金 辽宁省教育厅2008年度高等学校科研项目(2008752)
关键词 乙型肝炎 慢性 脯氨酸肽酶 纤维化 Hepatitis B, chronic Prolidase Fibrosis
  • 相关文献

参考文献2

  • 1Surazynski A, Miltyk W, Palka J, et al. Prolidase dependent regulation of collagen biosynthesis. Amino Acids, 2008,35(4): 731-738.
  • 2Kayadibi H, Otiltepe M, Yasar B, et al. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. Dig Dis Sci, 2009,54(8), 1764-1771.

同被引文献55

  • 1Liu JM, Garcia-Alvarez MC, Bignon J, et al. Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin β4 in neoplastic diseases [J]. Ann N Y Acad Sci, 2010, 1194: 53-59.
  • 2Mannherz HG, Hannappel E. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family [J]. Cell Motil Cytoskeleton, 2009, 66(10) : 839-851.
  • 3Paulussen M, Landuyt B, Schools L, et al. Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues [J]. Peptides, 2009, 30(10) : 1822-1832.
  • 4Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4 [J]. Ann N Y Acad Sci, 2010, 1194: 199-206.
  • 5Kryczka J, Wysocki T, Niewiarowska J. Thymosin beta 4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80 [J]. Ann N Y Acad Sci, 2010, 1194: 60-71.
  • 6Paulussen M, Landuyt B, Schools L, et al. Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues [J]. Peptides, 2009, 30(10) : 1833-1832.
  • 7Barnaeva E, Nadezhda A. Thymosin β4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-β receptor in human hepatic stellate cell [J]. Ann N Y Acad Sci, 2007, 1112: 154-160.
  • 8Brandt I, Scharpe S , Lambeir AM. Suggested functions for prolyl oligopeptidase:a puzzling paradox [J]. Clin Chim Acta, 2007, 377(1/ 2) : 154-160.
  • 9Myohanen TT, Venalainen JI, Garcia-Horsman JA, et al. Distribution of prolyl oligopeptidase in the mouse whole-body sections and periheral tissues [ J]. Histochem Cell Biol, 2008, 7 (130): 993-1003.
  • 10Garcia-Horsman JA, MannistoPT, Venalainen JI. On the role of prolyl oligopeptidase in health and disease [ J ]. Neuropeptides, 2007,41 (1) :1-24.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部